Since most of our investigations utilized neutrophils isolated from healthy volunteers, these results suggest that the reduction of effector functions against A. fumigatus is triggered by the BTK inhibition rather than the underlying disease requiring treatment with BTK inhibitors (e.g., chronic lymphocytic leukemia, graft-versus-host disease). The gene discussed is BTK; the disease is graft versus host disease.